← Leaderboards
Peter H Cygan
Pennsylvania State Univ Hershey Med Ctr
$863,350
Attributed
$863,350
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $172.7K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$863,350 · 1
By mechanism
K08$863,350 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Activated Partial Thromboplastin Time Measurement”
- Janet Galtes · Venarum Medical, Llc$2,565,076
- Ramkumar Abhishek · Abram Scientific, Inc.$1,887,517
- Dong Wang · Translational Sciences, Inc.$1,679,573
- Erin H Norris · Rockefeller University$1,092,595
- David Roh · Columbia University Health Sciences$950,032
- David Richard Myers · Emory University$787,745
Research focus
Activated Partial Thromboplastin Time MeasurementAdolescentAdultActivated Protein CAdverse OutcomeAdvocateAffectAllelesAnticoagulantsAntigensAreaAwardBenignBiological Adaptation To StressBiologyBiometryBlood Coagulation DisordersCareerCareer DevelopmentCarrier StateCategoriesCell Culture SystemCell LineCells
Grant awards (5)
Abnormal Bleeding Risk in Female Hemophilia A Carriers$172,670
K08 · FY2025 · HL · contact PI
Abnormal Bleeding Risk in Female Hemophilia A Carriers$172,670
K08 · FY2024 · HL · contact PI
Abnormal Bleeding Risk in Female Hemophilia A Carriers$172,670
K08 · FY2023 · HL · contact PI
Abnormal Bleeding Risk in Female Hemophilia A Carriers$172,670
K08 · FY2022 · HL · contact PI
Abnormal Bleeding Risk in Female Hemophilia A Carriers$172,670
K08 · FY2021 · HL · contact PI